11-2587630-C-T

Variant names:

• chr11-2587630-C-T
• rs199472776
• NM_000218.3:c.1189C>T

Variant summary

Our verdict is Uncertain significance. The variant received 3 ACMG points: 3P and 0B. PM1 PP2

The NM_000218.3(KCNQ1):​c.1189C>T​(p.Arg397Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00022 in 1,613,988 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R397Q) has been classified as Uncertain significance.

• Frequency:
  • Genomes: 𝑓 0.00012 (0 hom., cov: 33)
  • Exomes 𝑓: 0.00023 (0 hom.)
• Consequence: KCNQ1 NM_000218.3 missense
• Clinical Significance: Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:5 U:13 B:1 O:1
• Conservation: PhyloP100: 0.958
• Publications: 22 publications found

Genes affected

KCNQ1 (HGNC:6294): (potassium voltage-gated channel subfamily Q member 1) This gene encodes a voltage-gated potassium channel required for repolarization phase of the cardiac action potential. This protein can form heteromultimers with two other potassium channel proteins, KCNE1 and KCNE3. Mutations in this gene are associated with hereditary long QT syndrome 1 (also known as Romano-Ward syndrome), Jervell and Lange-Nielsen syndrome, and familial atrial fibrillation. This gene exhibits tissue-specific imprinting, with preferential expression from the maternal allele in some tissues, and biallelic expression in others. This gene is located in a region of chromosome 11 amongst other imprinted genes that are associated with Beckwith-Wiedemann syndrome (BWS), and itself has been shown to be disrupted by chromosomal rearrangements in patients with BWS. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Aug 2011]

KCNQ1 Gene-Disease associations (from GenCC):

• long QT syndrome

  Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
• long QT syndrome 1

  Inheritance: AD, AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
• Jervell and Lange-Nielsen syndrome

  Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
• Jervell and Lange-Nielsen syndrome 1

  Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), G2P
• atrial fibrillation, familial, 3

  Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
• short QT syndrome

  Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: ClinGen, Orphanet
• short QT syndrome type 2

  Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
• familial atrial fibrillation

  Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
• Jervell and Lange-Nielsen syndrome

  Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
• hypertrophic cardiomyopathy

  Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

ACMG classification

Our verdict: Uncertain_significance. The variant received 3 ACMG points.

• PM1: In a hotspot region, there are 3 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 3 benign, 21 uncertain in NM_000218.3
• PP2: Missense variant in the gene, where a lot of missense mutations are associated with disease in ClinVar. The gene has 212 curated pathogenic missense variants (we use a threshold of 10). The gene has 12 curated benign missense variants. Gene score misZ: 1.8321 (below the threshold of 3.09). Trascript score misZ: 0.90233 (below the threshold of 3.09). GenCC associations: The gene is linked to short QT syndrome type 2, long QT syndrome 1, Jervell and Lange-Nielsen syndrome 1, long QT syndrome, short QT syndrome, Jervell and Lange-Nielsen syndrome, hypertrophic cardiomyopathy, familial atrial fibrillation, atrial fibrillation, familial, 3.

Transcripts

RefSeq

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	MANE	Protein	UniProt
KCNQ1	NM_000218.3	c.1189C>T	p.Arg397Trp	missense_variant	Exon 9 of 16	ENST00000155840.12	NP_000209.2

Ensembl

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	TSL	MANE	Protein	Appris	UniProt
KCNQ1	ENST00000155840.12	c.1189C>T	p.Arg397Trp	missense_variant	Exon 9 of 16	1	NM_000218.3	ENSP00000155840.2

Frequencies

GnomAD3 genomes AF: 0.000125 AC: 19 AN: 152204 Hom.: 0 Cov.: 33

Gnomad AFR AF: 0.00

Gnomad AMI AF: 0.00

Gnomad AMR AF: 0.00

Gnomad ASJ AF: 0.00144

Gnomad EAS AF: 0.00

Gnomad SAS AF: 0.00

Gnomad FIN AF: 0.00

Gnomad MID AF: 0.00

Gnomad NFE AF: 0.000206

Gnomad OTH AF: 0.00

GnomAD2 exomes AF: 0.000199 AC: 50 AN: 251342 AF XY: 0.000199

Gnomad AFR exome AF: 0.00

Gnomad AMR exome AF: 0.0000578

Gnomad ASJ exome AF: 0.000893

Gnomad EAS exome AF: 0.00

Gnomad FIN exome AF: 0.00

Gnomad NFE exome AF: 0.000317

Gnomad OTH exome AF: 0.000163

GnomAD4 exome AF: 0.000230 AC: 336 AN: 1461666 Hom.: 0 Cov.: 32 AF XY: 0.000237 AC XY: 172 AN XY: 727148

African (AFR) AF: 0.0000597 AC: 2 AN: 33480

American (AMR) AF: 0.0000447 AC: 2 AN: 44722

Ashkenazi Jewish (ASJ) AF: 0.000650 AC: 17 AN: 26134

East Asian (EAS) AF: 0.00 AC: 0 AN: 39700

South Asian (SAS) AF: 0.0000348 AC: 3 AN: 86258

European-Finnish (FIN) AF: 0.00 AC: 0 AN: 53218

Middle Eastern (MID) AF: 0.000347 AC: 2 AN: 5768

European-Non Finnish (NFE) AF: 0.000261 AC: 290 AN: 1112000

Other (OTH) AF: 0.000331 AC: 20 AN: 60386

GnomAD4 genome AF: 0.000125 AC: 19 AN: 152322 Hom.: 0 Cov.: 33 AF XY: 0.000134 AC XY: 10 AN XY: 74480

African (AFR) AF: 0.00 AC: 0 AN: 41572

American (AMR) AF: 0.00 AC: 0 AN: 15302

Ashkenazi Jewish (ASJ) AF: 0.00144 AC: 5 AN: 3472

East Asian (EAS) AF: 0.00 AC: 0 AN: 5182

South Asian (SAS) AF: 0.00 AC: 0 AN: 4830

European-Finnish (FIN) AF: 0.00 AC: 0 AN: 10624

Middle Eastern (MID) AF: 0.00 AC: 0 AN: 294

European-Non Finnish (NFE) AF: 0.000206 AC: 14 AN: 68022

Other (OTH) AF: 0.00 AC: 0 AN: 2112

Alfa AF: 0.000290 Hom.: 0

Bravo AF: 0.000147

ESP6500AA AF: 0.00 AC: 0

ESP6500EA AF: 0.000582 AC: 5

ExAC AF: 0.000165 AC: 20

EpiCase AF: 0.000600

EpiControl AF: 0.000652

ClinVar

Significance: Conflicting classifications of pathogenicity

Submissions summary: Pathogenic:5 Uncertain:13 Benign:1 Other:1

Revision: criteria provided, conflicting classifications

Submissions by phenotype

Long QT syndrome Pathogenic:2 Uncertain:2 Benign:1

Sep 23, 2024

All of Us Research Program, National Institutes of Health

Significance: Uncertain significance

Review Status: criteria provided, single submitter

Collection Method: clinical testing

This missense variant replaces arginine with tryptophan at codon 397 of the KCNQ1 protein. Computational prediction suggests that this variant may have deleterious impact on protein structure and function (internally defined REVEL score threshold >= 0.7, PMID: 27666373). Functional studies have shown that this variant may result in reduced potassium ionic current (PMID: 23571586) and reduced ATP sensitivity (PMID: 24190995). This variant has been reported in individuals with a family history of long QT syndrome (PMID: 17470695), in one individual with catecholaminergic polymorphic ventricular tachycardia (PMID: 32553227), in individuals with sudden death (PMID: 23571586, 24440382), and in a stillbirth case (PMID: 30615648). This variant has also been identified in individuals with normal QTc intervals (PMID: 26159999) and showed no significant association with prolonged QTc interval in the Icelandic population (PMID: 37449562). This variant occurs at an appreciable frequency in the general population and has been identified in 53/282726 chromosomes by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. -

Jan 08, 2024

Dept of Medical Biology, Uskudar University

Significance: Likely pathogenic

Review Status: criteria provided, single submitter

Collection Method: research

Criteria: PS4_Strong, PS3_Supporting, PP3 -

Jun 01, 2014

CSER _CC_NCGL, University of Washington

Significance: Likely benign

Review Status: flagged submission

Collection Method: research

- -

Jan 23, 2025

Labcorp Genetics (formerly Invitae), Labcorp

Significance: Uncertain significance

Review Status: criteria provided, single submitter

Collection Method: clinical testing

This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 397 of the KCNQ1 protein (p.Arg397Trp). This variant is present in population databases (rs199472776, gnomAD 0.08%). This missense change has been observed in individual(s) with clinical features of KCNQ1-related conditions and/or long QT syndrome (PMID: 17470695, 19841300, 24440382, 32553227, 34505893, 37937776). ClinVar contains an entry for this variant (Variation ID: 52970). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed for this missense variant. However, the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on KCNQ1 protein function. Experimental studies have shown that this missense change affects KCNQ1 function (PMID: 23571586, 24190995). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Jun 14, 2016

Illumina Laboratory Services, Illumina

Significance: Likely pathogenic

Review Status: criteria provided, single submitter

Collection Method: clinical testing

The c.1189C>T (p.Arg397Trp) variant has been identified in a heterozygous state in at least seven patients with clinically-diagnosed long QT syndrome, in a heterozygous state in three individuals with an unclear clinical diagnosis, and in a heterozygous state in two unaffected individuals (Moss et al. 2007; Kapa et al. 2009; Kapplinger et al. 2009; Amin et al. 2012; Ghouse et al. 2015). The p.Arg397Trp variant was absent from 2300 controls but is reported at a frequency of 0.00058 in the European American population of the Exome Sequencing Project. Functional studies of electrophysiological properties in HEK293 cells and Xenopus oocytes demonstrated that the p.Arg397Trp variant reduced the hIK currents and ATP sensitivity of the channel (Crotti et al. 2013; Li et al. 2013). Based on the evidence, the p.Arg397Trp variant is classified as likely pathogenic for long QT syndrome. -

Long QT syndrome 1 Pathogenic:2 Uncertain:1

Nov 21, 2018

Equipe Genetique des Anomalies du Developpement, Université de Bourgogne

Significance: Likely pathogenic

Review Status: criteria provided, single submitter

Collection Method: clinical testing

- -

Mar 25, 2015

Genomic Diagnostic Laboratory, Division of Genomic Diagnostics, Children's Hospital of Philadelphia

Significance: Likely pathogenic

Review Status: criteria provided, single submitter

Collection Method: clinical testing

- -

Sep 04, 2023

Molecular Genetics, Royal Melbourne Hospital

Significance: Uncertain significance

Review Status: criteria provided, single submitter

Collection Method: clinical testing

This sequence change in KCNQ1 is predicted to replace arginine with tryptophan at codon 397, p.(Arg397Trp). The arginine residue is moderately conserved (100 vertebrates, UCSC), and is located in the cytoplasmic region. There is a large physicochemical difference between arginine and tryptophan. The highest population minor allele frequency in the population database gnomAD v2.1 is 0.03% (39/129,098 alleles) in the European non-Finnish population. This variant has been reported in multiple probands with KCNQ1-related cardiac arrhythmias (PMID: 19841300, 31737537). An in vitro functional assay using HEK293T cells showed a decrease in current density indicating that this variant impacts protein function (PMID: 23571586). Another functional study using a patch clamp assay in Xenopus oocytes showed a partial loss of conduction in the presence of this mutant and a complete loss of conduction in combination with another mutant suggestive that this variant impacts protein function (PMID: 24190995). Computational evidence predicts a deleterious effect for the missense substitution (REVEL = 0.76). Based on the classification scheme RMH Modified ACMG/AMP Guidelines v1.6.1, this variant is classified as a VARIANT OF UNCERTAIN SIGNIFICANCE. Following criteria are met: PP3, PS3_Supporting -

not specified Uncertain:2

Jan 29, 2019

Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine

Significance: Uncertain significance

Review Status: criteria provided, single submitter

Collection Method: clinical testing

The p.Arg397Trp variant in KCNQ1 has been reported in 9 individuals with LQTS (Moss 2007, Kapplinger 2009, Giudicessi 2012, Amin 2012). However, it has also been detected in asymptomatic individuals (Ghouse 2015, Taylor 2015) and in 0.03% (39/129098) of European chromosomes and 0.09% (9/10364) of Ashkenazi Jewish chromosomes by gnomAD (http://gnomad.broadinstitute.org). This variant has been reported in ClinVar (Variation ID 52970). In vitro functional studies provide some evidence that the p.Arg397Trp variant may impact protein function (Li 2013); however, these types of assays may not accurately represent biological function. Computational prediction tools and conservation analysis support an impact to the protein, though this information is not predictive enough to determine pathogenicity. In summary, due to the presence of conflicting evidence, the clinical significance of the p.Arg397Trp variant is uncertain. ACMG/AMP Criteria applied: BS1_Supporting, PP3. -

Jun 10, 2024

Women's Health and Genetics/Laboratory Corporation of America, LabCorp

Significance: Uncertain significance

Review Status: criteria provided, single submitter

Collection Method: clinical testing

Variant summary: KCNQ1 c.1189C>T (p.Arg397Trp) results in a non-conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.0002 in 251342 control chromosomes, predominantly at a frequency of 0.00032 within the Non-Finnish European subpopulation in the gnomAD database. The observed variant frequency within Non-Finnish European control individuals in the gnomAD database is approximately 4 fold of the estimated maximal expected allele frequency for a pathogenic variant in KCNQ1 causing Long QT Syndrome phenotype (8.3e-05). c.1189C>T has been reported in the literature in many individuals affected with Long QT Syndrome (e.g., Moss_2007, Kapa_2009, Kapplinger_2009, Amin_2012) as well as an in an intrauterine fetal death (e.g., Crotti_2013) and a sillbirth case (e.g., Sahlin_2019). However, co-segregation data was not provided to confirm causality in these cases and in some cases, co-occurring variants of uncertain significance were reported. Therefore, these data do not allow any conclusion about variant significance. Several publications report experimental evidence evaluating an impact on protein function, finding that the variant reduced the slowly activating K+ channel current densities by >70% compared to wild type and reduced ATP sensitivity as well (e.g., Li_2013, Crotti_2013). The following publications have been ascertained in the context of this evaluation (PMID: 22199116, 23571586, 19841300, 25854863, 24190995, 17470695, 30615648). ClinVar contains an entry for this variant (Variation ID: 52970). Based on the evidence outlined above, the variant was classified as uncertain significance. -

not provided Uncertain:2

Apr 01, 2025

CeGaT Center for Human Genetics Tuebingen

Significance: Uncertain significance

Review Status: criteria provided, single submitter

Collection Method: clinical testing

KCNQ1: PS3:Supporting -

Jul 01, 2025

GeneDx

Significance: Uncertain significance

Review Status: criteria provided, single submitter

Collection Method: clinical testing

Reported in association with LQTS or sudden death and in individuals referred for LQTS genetic testing; however, the majority of these publications did not provide specific clinical details or familial segregation data (PMID: 17470695, 19841300, 19716085, 23571586, 24440382, 34505893); Identified in a patient with CPVT in published literature (PMID: 32553227); Identified in the homozygous state in a patient with neonatal diabetes (PMID: 39055936); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 29197658, 25637381, 25985138, 19716085, 22378279, 22949429, 19841300, 23571586, 26159999, 24440382, 32048431, 32233023, 31737537, 30615648, 31019283, 28988457, 34426522, 34398675, 35008927, 34505893, 34621001, RidaM2023[Preprint], 24190995, 35534676, 22199116, 22581653, 17470695, 39055936, 32553227, 37937776, 22456477, 37449562, 36496179) -

Congenital long QT syndrome Uncertain:1 Other:1

-

Cardiovascular Biomedical Research Unit, Royal Brompton & Harefield NHS Foundation Trust

Significance: not provided

Review Status: no classification provided

Collection Method: literature only

This variant has been reported as associated with Long QT syndrome in the following publications (PMID:17470695;PMID:19716085;PMID:19841300). This is a literature report, and does not necessarily reflect the clinical interpretation of the Imperial College / Royal Brompton Cardiovascular Genetics laboratory. -

Jun 14, 2016

Illumina Laboratory Services, Illumina

Significance: Uncertain significance

Review Status: criteria provided, single submitter

Collection Method: clinical testing

- -

Wolff-Parkinson-White pattern Pathogenic:1

Jul 14, 2017

Lupski Lab, Baylor-Hopkins CMG, Baylor College of Medicine

Significance: Likely pathogenic

Review Status: no assertion criteria provided

Collection Method: research

This variant was identified in an individual with Wolff-Parkinson-White syndrome -

Atrial fibrillation, familial, 3;C1865019:Short QT syndrome type 2;C4551509:Jervell and Lange-Nielsen syndrome 1;C4551647:Long QT syndrome 1 Uncertain:1

Jun 19, 2020

New York Genome Center

Significance: Uncertain significance

Review Status: criteria provided, single submitter

Collection Method: clinical testing

The c.1189C>T (p.Arg397Trp) variant identified in the KCNQ1 gene substitutes a well conserved Arginine for Tryptophan at amino acid 397/677 (exon 9/16), and is also referred to asp.Arg270Trp annotated from transcript NM_181798.1. This variant is reported in gnomAD with an allele frequency of 1.26e-4 (v3.0; 18 heterozygotes, 0 homozygotes)and 1.88e-4 (v2.1.1; 53 heterozygotes, 0 homozygotes). In silico algorithms predict this variant to be Deleterious (SIFT; score: 0.001), Damaging (Provean; score: -3.32),and Pathogenic (REVEL; score: 0.7599) to the function of the canonical transcript. The p.Arg397 residue is in the intracellular C-terminal domain of KCNQ1 (UniProtKB:P51787). This variant has been reported many times in ClinVar with varying interpretations including Likely Pathogenic, Benign, and a Variant of Uncertain Significance (VarID:52970). The c.1189C>T (p.Arg397Trp) variant identified here has been reported in several affected individuals in the literature [PMID:17470695;PMID:19841300;PMID:22199116;PMID:22456477;PMID:24440382], however many of these studies were panel based and examined only a small number of potentially causative genes. Functional studies suggest the p.Arg397Trp variant leads to reduced current densities [PMID:23571586;PMID:24190995], and may be involved in coordination of ATP binding [PMID:24190995]. While it has been observed in several affected individuals and in vitro functional studies suggest an effect on current density, the presence of this variant at an allele frequency higher than expected in control databases leave some uncertainty regarding its pathogenicity. Given that, the c.1189C>T (p.Arg397Trp) variant identified in the KCNQ1 gene is reported as a Variant of Uncertain Significance. -

Familial atrial fibrillation Uncertain:1

Jun 14, 2016

Illumina Laboratory Services, Illumina

Significance: Uncertain significance

Review Status: criteria provided, single submitter

Collection Method: clinical testing

- -

Cardiovascular phenotype Uncertain:1

May 06, 2025

Ambry Genetics

Significance: Uncertain significance

Review Status: criteria provided, single submitter

Collection Method: clinical testing

The p.R397W variant (also known as c.1189C>T), located in coding exon 9 of the KCNQ1 gene, results from a C to T substitution at nucleotide position 1189. The arginine at codon 397 is replaced by tryptophan, an amino acid with dissimilar properties. This variant has been previously reported in individuals with suspicion of long QT syndrome or unexplained fetal death (Moss AJ et al. Circulation. 2007;115(19):2481-9; Kapa S et al. Circulation. 2009;120(18):1752-60; Crotti L et al. JAMA. 2013;309(14):1473-82; Sahlin E et al. PLoS ONE, 2019 Jan;14:e0210017). In vitro functional studies have reported this alteration to result in altered ion channel function, but these experiments may not accurately reflect physiological conditions in vivo (Crotti L et al. JAMA. 2013;309(14):1473-82; Li Y et al. Proc Natl Acad Sci U.S.A. 2013;110(47):18922-7). Based on data from gnomAD, the frequency for this variant is above the maximum credible frequency for a disease-causing variant in this gene based on internally established thresholds (Karczewski et al. Nature. 2020 May;581(7809):434-443; Whiffin et al. Genet Med. 2017 10;19:1151-1158). This amino acid position is well conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the available evidence, the clinical significance of this variant remains unclear. -

Jervell and Lange-Nielsen syndrome Uncertain:1

Jun 14, 2016

Illumina Laboratory Services, Illumina

Significance: Uncertain significance

Review Status: criteria provided, single submitter

Collection Method: clinical testing

- -

Cardiac arrhythmia Uncertain:1

Mar 17, 2025

Color Diagnostics, LLC DBA Color Health

Significance: Uncertain significance

Review Status: criteria provided, single submitter

Collection Method: clinical testing

This missense variant replaces arginine with tryptophan at codon 397 of the KCNQ1 protein. Computational prediction suggests that this variant may have deleterious impact on protein structure and function. Functional studies have shown that this variant results in reduced potassium ionic current (PMID: 23571586) and reduced ATP sensitivity (PMID: 24190995). This variant has been reported in an individual with catecholaminergic polymorphic ventricular tachycardia (PMID: 32553227), in individuals with sudden death (PMID: 23571586, 24440382), and in an individual with stillbirth (PMID: 30615648). This variant has also been identified in individuals with normal QTc intervals (PMID: 26159999) and showed no significant association with prolonged QTc interval in the Icelandic population (PMID: 37449562). This variant has been reported in a homozygous individual with permanent neonatal diabetes melitus without cardiovascular symptoms (PMID: 39055936). His parents and brothers are heterozygous and healthy (PMID: 39055936). This variant occurs at an elevated frequency in the general population and has been identified in 53/282726 chromosomes by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. -

Computational scores

Source: dbNSFP v4.3

Name	Calibrated prediction	Score	Prediction
AlphaMissense	Benign	0.27
CardioboostArm	Pathogenic	0.95
BayesDel_addAF	Pathogenic	0.28	D
BayesDel_noAF	Pathogenic	0.47
CADD	Pathogenic	27
DANN	Pathogenic	1.0
DEOGEN2	Pathogenic	0.87	D;.;.
Eigen	Uncertain	0.31
Eigen_PC	Benign	0.20
FATHMM_MKL	Benign	0.64	D
LIST_S2	Uncertain	0.96	D;D;D
M_CAP	Pathogenic	0.81	D
MetaRNN	Uncertain	0.55	D;D;D
MetaSVM	Pathogenic	1.1	D
MutationAssessor	Uncertain	2.5	M;.;.
PhyloP100		0.96
PrimateAI	Uncertain	0.58	T
PROVEAN	Uncertain	-3.3	D;.;D
REVEL	Pathogenic	0.76
Sift	Uncertain	0.0010	D;.;D
Sift4G	Uncertain	0.0070	D;.;D
Polyphen		1.0	D;.;D
Vest4		0.89
MVP		0.98
MPC		1.1
ClinPred		0.27	T
GERP RS		4.7
Varity_R		0.43
gMVP		0.85
Mutation Taster		=5/95	disease causing (ClinVar)

Splicing

Name	Calibrated prediction	Score	Prediction
SpliceAI score (max)		0.0		Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Other links and lift over

dbSNP: rs199472776; hg19: chr11-2608860; COSMIC: COSV106345973;